Literature DB >> 1630615

Atypical MR presentation of Wilson disease: a possible consequence of paramagnetic effect of copper?

P Brugieres1, C Combes, F Ricolfi, J D Degos, J Poirier, A Gaston.   

Abstract

A 53-year-old patient with Wilsons's disease and without autonomic dysfunction presented on T2-weighted MR study an atypical decreased signal intensity of the putamina and the caudate nuclei. Possible explanations of such a signal abnormalities are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1630615     DOI: 10.1007/bf00596341

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  6 in total

1.  Nuclear magnetic resonance (NMR) imaging in Wilson disease.

Authors:  G A Lawler; J M Pennock; R E Steiner; W J Jenkins; S Sherlock; I R Young
Journal:  J Comput Assist Tomogr       Date:  1983-02       Impact factor: 1.826

2.  Improvement of cerebral CT abnormalities following liver transplantation in a patient with Wilson disease.

Authors:  W E Rothfus; W L Hirsch; J J Malatack; I Bergman
Journal:  J Comput Assist Tomogr       Date:  1988 Jan-Feb       Impact factor: 1.826

3.  Nuclear magnetic resonance of iron and copper disease states.

Authors:  V M Runge; J A Clanton; F W Smith; J Hutchison; J Mallard; C L Partain; A E James
Journal:  AJR Am J Roentgenol       Date:  1983-11       Impact factor: 3.959

4.  Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging.

Authors:  S Starosta-Rubinstein; A B Young; K Kluin; G Hill; A M Aisen; T Gabrielsen; G J Brewer
Journal:  Arch Neurol       Date:  1987-04

5.  Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.

Authors:  B P Drayer; W Olanow; P Burger; G A Johnson; R Herfkens; S Riederer
Journal:  Radiology       Date:  1986-05       Impact factor: 11.105

6.  Multiple system atrophy (Shy-Drager syndrome): MR imaging.

Authors:  B Pastakia; R Polinsky; G Di Chiro; J T Simmons; R Brown; L Wener
Journal:  Radiology       Date:  1986-05       Impact factor: 11.105

  6 in total
  9 in total

Review 1.  Neuroimaging in Wilson disease.

Authors:  H N van Wassenaer-van Hall
Journal:  Metab Brain Dis       Date:  1997-03       Impact factor: 3.584

Review 2.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

3.  Decreased signal intensity of the putamen and the caudate nucleus in Wilson disease of the brain.

Authors:  A Mironov
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

4.  The claustrum on MRI: normal anatomy, and the bright claustrum as a new sign in Wilson's disease.

Authors:  R N Sener
Journal:  Pediatr Radiol       Date:  1993

5.  Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI.

Authors:  Maria do Desterro Leiros da Costa; Mariana Spitz; Luiz Alberto Bacheschi; Claudia Costa Leite; Leandro Tavares Lucato; Egberto Reis Barbosa
Journal:  Neuroradiology       Date:  2009-05-29       Impact factor: 2.804

6.  Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease.

Authors:  G Schlaug; H Hefter; B Nebeling; V Engelbrecht; P Weiss; G Stöcklin; R J Seitz
Journal:  J Neurol       Date:  1994-10       Impact factor: 4.849

7.  Wilson's disease: MRI demonstration of cavitations in basal ganglia and thalami.

Authors:  R N Sener
Journal:  Pediatr Radiol       Date:  1993

8.  Case report: concordant traumatic brainstem contusion delayed diagnosis in a young man with Wilson's disease.

Authors:  A Marcus; C Ammermann; M Klein; M H Schmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  1995-01       Impact factor: 4.785

9.  MR imaging of CNS involvement in children affected by chronic liver disease.

Authors:  E Genovese; M Maghnie; G Maggiore; C Tinelli; F Lizzoli; C De Giacomo; S Pozza; R Campani
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.